etf1 min
HLB制药公告约1200亿韩元有偿增资计划
发布: · 来源: mk.co.kr
一句$话总结: 科斯达克上市公司HLB制药于2026年5月13日公告，将以股东配售后失权股公开募集方式实施规模为1200亿1800韩元的有偿增资。
广告
Get notifications
HLB制药于2026年5月13日公告，将实施规模为1200亿1800韩元的有偿增资。此次方式为先向现有股东优先配售，随后将产生的失权股向普通投资者公开募集，即股东配售后失权股公开募集。该有偿增资是科斯达克上市公司HLB制药通过公告披露的融资计划。新发行股份为普通股，但根据原文摘要，具体数量仅能部分确认。投资者需继续关注后续公告中的最终发行价和认购日程等信息。来源: mk.co.kr
广告
매일 5분 안에 핵심 뉴스
Partner picks
Relevant partner links for this story
A lightweight commerce block designed to add monetization without breaking reading flow.
Coupang PartnersKR conversion
Good fit for Korea-based visitors ready to buy.
View offerAliExpressBudget picks
Works well for price-sensitive gadget and desk-tool traffic.
View offerAmazon AssociatesGlobal reach
Useful for books, work tools, and international shoppers.
View offerThis module may include affiliate links that earn a commission from qualifying purchases. ETF와이어
Sponsored
Get notifications
Subscribe to our daily digest
广告
매일 5분 안에 핵심 뉴스
